NASDAQ · BLI
Healthcare · Biotechnology
$1.20
Down-$0.08 (-5.88%)
Updated Sep 12, 2026, 6:57 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
BLI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning BLI.
BLI research
Company profile and research snapshot.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2022 | Morgan Stanley | Underweight | — |
| Aug 10, 2022 | BTIG | Neutral | — |
| Aug 10, 2022 | JP Morgan | Neutral | — |
| May 10, 2022 | Morgan Stanley | Equal-Weight | — |
| Feb 25, 2022 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
Seeking Alpha · Jan 27, 2023
ARK Invest’s 13F portfolio value decreased from $14.35B to $11.54B this quarter. Click here for an ongoing analysis of the changes made to its portfolio on a quarterly basis.
Benzinga · Jan 10, 2023
Berkeley Lights Inc (NASDAQ: BLI) announced preliminary FY22 revenue of $78-$78.5 million, compared to $85.4 million in 2021, missing the consensus of $85.36 million. The company said the results were lower-than-expected due to delays in several Beacon platform placements, which are now expected in 2023, and lower revenue from partnership and services contracts. During Q4 FY22, the company observed a tightening macroeconomic environment. Related: Berkeley Lights Scoops Up IsoPlexis, Creating A Premier Functional Cell Biology Company. Stifel writes ...Full story available on Benzinga.com
Benzinga · Dec 23, 2022
Gainers Expion360 Inc. (NASDAQ: XPON) shares jumped 175% to $2.70 after the company announced it has been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer to be branded and sold by a top U.S. sports utility vehicle manufacturer. AMC Entertainment Holdings, Inc. (NYSE: APE) rose 50% to $1.79 after jumping 75% on Thursday. AMC announced it would sell APE units to Antara Capital at an average price of $0.66 per share. Immuron Limited (NASDAQ: IMRN) rose 44.2% to $2.4963 after the company received FDA approval for Travelan IND application. Core Scientific, Inc. (NASDAQ: CORZ) rose 41.8% to $0.1250 after gaining 73% on Thursday. Core Scientific recently filed for Chapter 11 bankruptcy. Concord Medical Services Holdings Limited (NYSE: CCM) gained 24.3% to $1.69. iMedia Brands, Inc. (NASDAQ: IMBI) shares rose 23.4% to $0.5797 after the company agreed to sell three buildings for $48 million. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 22.4% to $2.29. Blue Apron Holdings, Inc. (NYSE: APRN) rose 20.3% to $1.1489 after gaining over 11% on Thursday. DBV Technologies S.A. (NASDAQ: DBVT) shares rose 20% to $1.41 after the company announced the FDA has lifted the partial clinical hold on its VITESSE Phase 3 Pivotal Trial. TuSimple Holdings Inc. (NASDAQ: TSP) jumped 18.6% to $1.4950. Omeros Corporation (NASDAQ: OMER) shares gained 16.9% to $2.98. Omeros, last month, posted a narrower-than-expected quarterly loss. Exela Technologies, Inc. (NASDAQ: XELA) surged 12% to $0.0955. Viveve Medical, Inc. (NASDAQ: VIVE) gained 12% to $0.4025. Airspan Networks Holdings Inc. (NYSE: MIMO) jumped 11.2% to $1.14. Hallador Energy Company (NASDAQ: HNRG) shares gained 10.9% to $10.86. Nine Energy Service, Inc. (NYSE: NINE) jumped 9.8% to ...
Benzinga · Dec 23, 2022
Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer available through SUV dealerships nationwide. Core Scientific, Inc. (NASDAQ: CORZ) rose 66% to $0.1464 in pre-market trading after gaining 73% on Thursday. Core Scientific recently filed for Chapter 11 bankruptcy. DBV Technologies S.A. (NASDAQ: DBVT) shares rose 38% to $1.63 in pre-market trading after the company said that the FDA has lifted partial clinical hold on VITESSE Phase 3 pivotal trial clinical trial that evaluates the modified viaskin peanut 250 patch in peanut-allergic children ages 4-7 years. Immuron Limited (NASDAQ: IMRN) rose 27.2% to $2.20 in pre-market trading after the company received FDA approval for Travelan IND application. AMC Entertainment Holdings, Inc. (NYSE: APE) rose 26.7% to $1.52 in pre-market trading after jumping 75% on Thursday. AMC announced it would sell APE units to Antara Capital at an average price of $0.66 per share. Swvl Holdings Corp. (NASDAQ: SWVL) rose 22.5% to $0.1347 in pre-market trading after gaining 10% on Thursday. iMedia Brands, Inc. (NASDAQ: IMBI) shares rose 17.4% to $0.5513 in pre-market trading after the company agreed to sell three buildings for $48 million. AIM ImmunoTech Inc. ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BLI.
No results
No recent SID articles mention BLI.
